Engraftment of human hematopoietic tissue to create a “human” immune system. |
Deficiencies in all the human immune cell types. |
Infect with HIV, including “transmitter/founder” viruses. |
Lack human innate immunity. |
Mice will succumb to “wasting” disease similar to humans. |
Inability to evaluate non-hematopoietic HIV interactions. |
Mice being created to more accurately reflect human innate/adaptive immunity. |
Estrus cycle/endocrine system different. |
Microbiome transplants being done. |
Restrictions on microbiome. |
Pharmacokinetic studies being initiated. |
Pharmacokinetics may be affected by mouse serum-binding antiretroviral drugs differently than humans. |
|
Pharmacogenomics are different from humans. |
|
Mice take several months to be created de novo and kept in controlled environment; expensive. |
|
Penile challenge has not been attempted. |